Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Also Known As
founded date
founders
Number of employees
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Forbion
Netherlands-based venture capital firm investing in life sciences and MedTech companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Seroba Life Sciences
Seroba is a life sciences venture capital firm investing in breakthrough healthcare technologies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund invests in therapeutic biotechnology companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Apple Tree Partners
Apple Tree Partners is a life sciences venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Financials
Investments47
BridgeBio Oncology Therapeutics
BridgeBio Oncology Therapeutics operates as a biopharmaceutical company.
total rounds
total raised
Engrail Therapeutics
Engrail Therapeutics develops transformative medicines for life-limiting nervous system diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
OWL
OstWestfalenLippe GmbH develops and promotes OWL as a technology hub.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits5
Mitobridge
Mitobridge develops small molecule therapeutics that enhance mitochondrial function with a focus on diseases with high unmet medical needs.
Sector
Subsector
Keywords
Location
total rounds
total raised
Colorescience
Colorescience is a luxury makeup line that focuses on creating high-quality products for the medical and resort spa sectors.
Sector
Subsector
Keywords
Location
total rounds
total raised
ArcherDX
ArcherDX is a biotech firm that specializes in cancer research.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders3
Christoph Westphal
Christoph Westphal is the Co-Founder, Chairman & Board Member at ImmuneID.
current job
Christoph Westphal
Richard Aldrich
Richard Aldrich is a co-founder of Concert Pharmaceuticals and has served as our Chairman of the Board since May 2006. Richard Aldrich co-founded Longwood Founders Fund in 2010, a fund that starts and invests in biotechnology companies, and currently serves as a Partner in the firm. Prior to Longwood, he was General Partner of RA Capital, a biotech investment fund he founded in 2001. Richard Aldrich was a co-founding employee of Vertex Pharmaceuticals where he held the position of Senior Vice President and Chief Business Officer and managed all commercial and operating functions from 1989 to 2001. Prior to joining Vertex, Richard Aldrich held several management positions at Biogen Inc. In addition to Concert, Richard Aldrich has co-founded and helped build several successful biotech companies including Sirtris Pharmaceuticals and Alnara Pharmaceuticals. Richard Aldrich received his undergraduate degree from Boston College, and an MBA from the Amos Tuck School at Dartmouth College.
current job
count Of Investments
Richard Aldrich
Michelle Dipp
Michelle Dipp, MD PhD is Co-Founder and Managing Partner at Biospring Partners, a life sciences technology growth equity firm. Michelle serves on the Board of Directors for Abzena. Michelle was a Managing Director at General Atlantic, a New York based global growth equity firm. Michelle Dipp launched their life sciences investment platform and was a member of the life sciences investment committee. Michelle Dipp served as a Board Observer for Ginkgo BioWorks and also served as a board member for PathAI and Immunocore. Michelle was a Co-Founder and former General Partner of a leading Boston-based healthcare investment firm, Longwood Fund. As a General Partner in Longwood Funds I, II, III, and IV, Michelle co-founded several portfolio companies for Longwood Fund, where she held senior management positions. In addition to her management positions, Michelle worked on the board of these portfolio companies including as Chairman of Axial Biotherapeutics. Michelle served on the board of Colorescience and also served as a board observer of both Bicycle Therapeutics and Pulmocide Ltd. Before joining Longwood, Michelle Dipp was GlaxoSmithKline’s (GSK) Senior Vice President of the Centre of Excellence for External Drug Discovery (CEEDD). During Michelle Dipp's time she also served in GSK’s global business development group as Vice President of Corporate Development at Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT was ultimately acquired by GlaxoSmithKline in 2008). Michelle began her investment career at the Wellcome Trust after completing her medical training. Michelle Dipp, MDPhD holds a Bachelor of Medicine and Bachelor of Surgery from the University of Oxford Medical School and a Doctor of Philosophy in Human Physiology from the University of Oxford, Brasenose College. Michelle currently serves on the Trustee Advisory Board for Beth Israel Deaconess Medical Center; Advisory Board for the Women’s Foundation of Boston; Board of Directors for Life Science Cares; Rockefeller University Council; Advisory Council for the American Museum of Natural History; Co-Founding Member of the Bowman Fund, Brasenose College Boat Club, Oxford University; and a member of the World Economic Forum’s Young Global Leaders.
current job
count Of Investments
Michelle Dipp
Employee Profiles14
Julie Mullen
Office coordinator and administrative assistant
Activity
Recent News5
The graph reveals the ratio (%) of positive news articles in a chosen time range